Form D · Other Technology
A-Alpha Bio, Inc.
Seattle, WA · CIK 0001789664
Offering snapshot reported Sep 8, 2021 · SEC filing
- Reported sold
- $20.3M Offering amount: $20.3M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 8, 2021 | Initial | $20,289,926 | No comparison | Not reported | SEC filing |
| Sep 30, 2019 | Initial | $2,844,988 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-412668
Source: Form D, filed Sep 8, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ben Askew | Director |
| Randolph Lopez Barrezueta | Director |
| Matt Mc Ilwain | Director |
| David Younger | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4000 Mason Road
Seattle, WA, 98195
Seattle, WA, 98195